OncoLens

AI that connects cancer patients to right care

Atlanta, Georgia, United States

Precision Medicine/Diagnostics CancerSeries A

A precision oncology solutions company.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out OncoLens on @MedStartr Today A precision oncology solutions company. #CancerOncology #PrecisionMedicineDiagnostics #Cancer #MedMo #MedStartrVentures

https://www.medstartr.ai/s/zFrZdzIRr2I

Get Involved in OncoLens

How We Help

Problem Statement

Fragmented cancer treatment planning due to disparate data sets and lack of collaboration between oncology care teams and stakeholders.

Core Technology

AI/NLP

Key Differentiators

Unifies disparate data sets, oncology care teams, and stakeholders on a singular platform; Simplifies tumor board management; Facilitates survivorship care planning; Automates accreditation and quality reporting; Uses proprietary AI/NLP to search structured and unstructured data within EMR systems

Clinical Focus

Oncology

Company Info

Business Model: Hybrid
Founded: 2019
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: www.oncolens.com/

Disease Areas

Cancer & Oncology

Technologies

NLPSaaSPlatformData InteroperabilityClinical WorkflowAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

Used by 225+ cancer centers and 45,000+ physicians; 70% increase in biomarker testing; 650 hours saved per cohort analysis; AI achieves 85-90% accuracy in patient identification; proven at academic and community centers nationwide.

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of OncoLens?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.